StockUK listing UK0MV5LSEHealthcareBalanced

Eurofins Scientific SE(0MV5) Stock Analysis | Healthcare

EUR --+0.00%
Reward55Moderate
Risk50Moderate
25%Data
EUR —+0.00 (+0.00%) Previous close · LSE
Market cap 1.45Bn
Reward Ratingⓘ55 Moderate reward assessment · 25% data coverage
Bottom 50% of stocksView factors
Risk Ratingⓘ50 Moderate risk assessment · 50% data coverage
Risk factors availableUnlock details

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

Educational tool only · More
Limited data coverage
We don't have enough public data on 0MV5 to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available yet for this stock
The overview tab requires data we don't have for this stock yet. The price chart is the most reliable view we have — try the Chart tab.
Earnings Ex-dividend

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

What is Eurofins Scientific SE?

Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide.

AI Brief Pro

The brief on Eurofins Scientific SE

The story behind the price, the case for and against, and what could go wrong. Open a part to read it.

What is Eurofins Scientific SE?

Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. It provides services, such as agroscience, including biological assessment, consumer and human, environmental safety, product chemistry, regulatory consultancy, and seed services; agro testing; assurance, including sustainability, audit, certification, quality inspection, QA-QC programme, and food and dietary supplement labelling services; biopharma, and clinical diagnostics. The company is listed on the LSE in UK, operating in the Healthcare sector, with a market capitalisation of 1.45B, and a P/E ratio of 21.9x.

Financial Highlights

Investment Breakdown

Growth
Moderate growth momentum — positive trajectory without breakout acceleration.
Profitability
Adequate profitability with some margin variability in recent periods.
Risk
Risk profile appears balanced versus broad market conditions.
Valuation
Valuation appears fair relative to current fundamentals.

OpenBook Logo Analysis

Reward: Moderate (55)

Similar stocks to compare

A short list of Diagnostics & Research names that are close enough in size to make side-by-side comparison useful.

All Healthcare stocks →
Company Information
IndustryDiagnostics & Research
P/E Ratio21.8874
Beta0.811
Insider Activity
12M windowAwaiting coverage
LSE director-dealings coverage launching later this year. The data feed is in development.